The emerging business models for digital therapeutics
Digital therapeutics (DTx) leverage technology to deliver evidence-based treatments for various health conditions, aiming to complement or replace traditional...
This website will offer limited functionality in this browser. We only support the recent versions of major browsers like Chrome, Firefox, Safari, and Edge.
CRA’s global team of medical device consultants supports MedTech clients in developing both product-specific and portfolio/corporate strategies. We deploy our deep understanding of the market environment, extensive prior experience in the medical device consulting space, and a multidisciplinary approach with each client project and deliverable.
CRA has deep expertise in creating commercial and PMA strategies along the MedTech product lifecycle. We can help you understand, demonstrate, and maximize value, and provide support throughout the different stages, including early and late development, launch, growth strategies, benchmarking and assessments, and defensive strategies for medical device marketing.
Digital therapeutics (DTx) leverage technology to deliver evidence-based treatments for various health conditions, aiming to complement or replace traditional...
The global medical devices market is projected to grow at 4.4% CAGR until 2025. But large medical devices with high initial procurement costs are experiencing...